|Articles|June 9, 2023

A Look at Climate Change and Mental Health

A wide variety of mental health concerns are related to climate change. Here is some recent coverage of these issues in Psychiatric Times®.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!

Related Content

A Psychiatrist's Reflections on the Country

ByFrank A. Clark, MD

September 11th 2025

Robert Jay Lifton, MD: Lifting Us Up From Our Human Abyss

ByH. Steven Moffic, MD

September 5th 2025

Lone Star Elegy

ByFrank A. Clark, MD

July 14th 2025

Whither Psychiatry? Faster, Higher, Stronger—Together

ByH. Steven Moffic, MD

June 3rd 2025

Reaffirming Evidence-Based Psychiatric Care: A Joint Statement on Psychotropic Medication Safety

ByJoseph F. Goldberg, MD,Heidi Anne Duerr, MPH

March 24th 2025

Latest CME

In-Person + Virtual Event

Real Psychiatry 2026

January 23-24, 2026

Video

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Michael Asbach, DMSc, PA-C; Erin Crown, MHS, PA-C, Psych-CAQ

Video

Optimizing Care for Patients With Tardive Dyskinesia

Amber Hoberg, MSN, APRN, PMHNP-BC; Erin Crown, PA-C, Psych-CAQ

Video

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Jonathan Meyer, MD; Jacob Hanaie, PharmD, APh, BCPP; Sanjai Rao, MD, DFAPA

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

(Pharmacist Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

A Look at Climate Change and Mental Health

Newsletter

Related Content

A Psychiatrist's Reflections on the Country

Robert Jay Lifton, MD: Lifting Us Up From Our Human Abyss

Lone Star Elegy

Whither Psychiatry? Faster, Higher, Stronger—Together

Reaffirming Evidence-Based Psychiatric Care: A Joint Statement on Psychotropic Medication Safety

Latest CME

Real Psychiatry 2026

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Optimizing Care for Patients With Tardive Dyskinesia

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(Pharmacist Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

Psychedelic PSX-001 for Generalized Anxiety Disorder: A Conversation With Lou Barbato, MD

The Concept of Mental Illness, and Why the DSM Approach Is Wrong

Quantifying Generative AI Use for Mental Health Advice Among Adolescents

Catatonia Crisis: Navigating the IV Lorazepam Shortage

The Future Directions of Psychedelics: A Conversation With Guy Goodwin, MD